Aiding in identifying individuals with an adaptive immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), indicating recent or prior infection. The test provides qualitative detection of serum total antibodies ((including IgG and IgM) against nucleocapsid protein of the SARS-CoV-2.
Please see https://www.pathology.med.umich.edu/covid-19-resources for additional information regarding COVID antibody and other COVID testing.
< 1.0 Index = Negative for antibodies (Nonreactive)
=/> 1.0 Index = Positive for antibodies (Reactive)
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
Collect specimen in SST tube. Centrifuge, aliquot and transport specimen refrigerated.
Do not freeze whole blood or any samples stored in the collection tube.
SARS-CoV-2 (COVID-19) Total Antibodies, Qualitative by CIA test is for in vitro diagnostic use under an FDA Emergency Use Authorization (EUA). In compliance with this authorization, please review Antibody Fact Sheet for Health Care Provider for more information.